Who We Are

Resono Ophthalmic is a pioneering Italian company specializing in the production of innovative therapeutic devices for eye care, particularly for treating dry eye disease.

The Rexon-Eye device harness the power of Quantum Molecular Resonance (QMR®), a patented technology designed to stimulate natural cellular and tissue regeneration through low-power, high-frequency
electric fields.

Global Reach

Our innovative approach has gained international acclaim, with ophthalmologists and optometrists worldwide incorporating the Rexon-
Eye into their practices.

The device is celebrated for its effectiveness in treating dry eye patients in various settings, including dry-eye centers and hospitals.

Our Mission & Vision

Our Vision

Our vision is to revolutionize patient care on a global scale by harnessing the power of cellular regeneration. We are committed to elevating the
quality of life for individuals worldwide, pioneering advancements in eye care through our innovative approach to treatment and healing, with a special focus on combating dry eye diseases.

Our Mission

Our mission is to lead the forefront of ophthalmic treatment through relentless scientific research and technological innovation, specializing in
the effective management and treatment of dry eye diseases.

We are dedicated to refining our services and solutions, effectively addressing this widespread condition. Our commitment lies in not just meeting but exceeding the standards of eye care, ensuring every advancement we make translates into improved patient outcomes and enriched lives, particularly for those suffering from the challenges of dry eye diseases.

Our Journey

Founded in 2014 as an Innovative Startup and evolving into an innovative SME in 2019, Resono Ophthalmic’s journey is a testament to our commitment to innovation in ophthalmology.

The inception of our company was driven by the vision to apply QMR technology to eye care, a concept supported by Telea Medical’s expertise in Business Development and Sales & Marketing.

Our collaboration with ophthalmologists and researchers led to the creation of the Rexon-Eye, our first product, specifically targeting dry eye disease, the most prevalent condition in the field.

Quality and Recognition

The Rexon-Eye has achieved CE marking, affirming its compliance with health, safety, and environmental protection standards within the European Economic Area.

We are actively pursuing additional certifications globally to bring our technology to more patients worldwide.

IMQ Certified